MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-01-0039515
Leemark Pharmaceutical Private Limited
Leemark Pharmaceutical Private Limited - pharma in Ajmer, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.81 Cr
▲ 11% YoY
Net profit · FY 2025
₹6.97 Lakh
Net margin 2.5%
EBITDA · FY 2025
₹10.07 Lakh
EBITDA margin 3.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Leemark Pharmaceutical Private Limited
Data last updated:
Leemark Pharmaceutical Private Limited is a private limited company based in Ajmer, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 May 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2010PTC031648. Its GSTIN is 08AABCL7734L1Z4 (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kamal Yadav and Goutam Chand Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 131 Parshavnath Colony Ana Sagar Circular Road, Ajmer, Rajasthan, India – 305001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.81 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹6.97 Lakh (net margin 2.5%) and EBITDA of ₹10.07 Lakh (EBITDA margin 3.6%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
Leemark Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-01-0039515). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232RJ2010PTC031648
Registration Number 031648
Incorporation Date 01 May 2010
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-01-0039515
Key People
Kamal Yadav Director Goutam Chand Jain Director Recognitions & Rankings of Leemark Pharmaceutical
Contact details
Leemark Pharmaceutical Private Limited's registered office is in Ajmer, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – 131 Parshavnath Colony Ana Sagar Circular Road, Ajmer, Rajasthan, India – 305001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Leemark Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Leemark Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Leemark Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Leemark Pharmaceutical Private Limited, buy the company report.
Financials of Leemark Pharmaceutical Private Limited
FY 2025 filings availableLeemark Pharmaceutical Private Limited reported revenue of ₹2.81 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹2.81 Cr ▲ 11%
Net profit · FY 2025
₹6.97 Lakh margin 2.5%
EBITDA · FY 2025
₹10.07 Lakh margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 8%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 82%
3 years · compounded
▲ 50%
5 years · compounded
▲ 17%
Revenue rose 11% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Leemark Pharmaceutical Private Limited, buy the company report.
Board of directors of Leemark Pharmaceutical Private Limited
Leemark Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Yadav | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
| Goutam Chand Jain Also directs: Arihant Medicare Private Limited | Director | 01 May 2010 | 16 Years 5 Months | Current |
Peer comparison
Leemark Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meditech Overseas Private Limited | ₹2.81 Cr (FY 2024) | 59.0% | Lucknow, Uttar Pradesh, India | |||
| SN Cotton Collection Private Limited | ₹2.81 Cr (FY 2025) | 47.0% | Jalandhar, Punjab, India | |||
| Priyanka Engineering Projects Private Limited | ₹2.81 Cr (FY 2023) | 183.0% | Kolkata, West Bengal, India | |||
| Tejas Enterprises Private Limited | ₹2.81 Cr (FY 2025) | -47.0% | New Delhi, Delhi, India | |||
| Ui International Private Limited | ₹2.81 Cr (FY 2025) | 129.0% | Faridabad, Haryana, India | |||
| Leemark Pharmaceutical Private Limitedthis company | ₹2.81 Cr (FY 2025) | ₹6.97 Lakh | 2.5% | 11.0% | Ajmer, Rajasthan, India | |
| Mayur Designer Private Limited | ₹2.81 Cr (FY 2025) | -1.0% | Kolkata, West Bengal, India | |||
| Aneco Industries Private Limited | ₹2.81 Cr (FY 2025) | -97.0% | Mumbai, Maharashtra, India | |||
| Ma Bhabatarini Agro Products Private Limited | ₹2.81 Cr (FY 2024) | 7.0% | Bardhaman, West Bengal, India | |||
| Jinraj Engineering Company Pvt Ltd. | ₹2.81 Cr (FY 2024) | 91.0% | Madhya Pradesh, India | |||
| Stubborn Factory Private Limited | ₹2.81 Cr (FY 2024) | 28.0% | New Delhi, Delhi, India |
To see the full peer comparison of Leemark Pharmaceutical Private Limited, buy the company report.
Auditor
Leemark Pharmaceutical Private Limited is audited by MANISH K MEHTA AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH K MEHTA AND COMPANY | FY 2017 | 012815C |
Shareholding
The shareholding of Leemark Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Leemark Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Leemark Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Leemark Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Leemark Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AABCL7734L1Z4 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Leemark Pharmaceutical Private Limited, buy the company report.
Recent activity
Leemark Pharmaceutical Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Kamal Yadav was appointed as Director on 22 Feb 2021.
AGM
Leemark Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Leemark Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Appointed
Kamal Yadav was appointed as Director.
Ceased
Mukesh Gadiya ceased to be Director.
Appointed
Goutam Chand Jain was appointed as Director.
Incorporation
01 May 2010
Leemark Pharmaceutical Private Limited was registered on 01 May 2010 with Roc Jaipur & aged 16 years 5 months as per MCA records.
Frequently asked questions
Leemark Pharmaceutical is an active private limited company based in Ajmer, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 May 2010 (16+ years old) and is registered under CIN U24232RJ2010PTC031648.
Leemark Pharmaceutical has 2 current directors:
- Kamal Yadav - Director
- Goutam Chand Jain - Director
The latest financial statements of Leemark Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Leemark Pharmaceutical is 08AABCL7734L1Z4, registered in Rajasthan.
The CIN (Corporate Identification Number) of Leemark Pharmaceutical is U24232RJ2010PTC031648. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leemark Pharmaceutical was incorporated on 01 May 2010, making it 16+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Leemark Pharmaceutical by revenue are Meditech Overseas Private Limited, SN Cotton Collection Private Limited, Priyanka Engineering Projects Private Limited, Tejas Enterprises Private Limited, Ui International Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Kamal Yadav was appointed as Director on 22 Feb 2021. Mukesh Gadiya ceased to be Director on 22 Feb 2021. Goutam Chand Jain was appointed as Director on 01 May 2010.
Yes, Leemark Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-01-0039515).
The registered office of Leemark Pharmaceutical is at Plot No – 131 Parshavnath Colony Ana Sagar Circular Road, Ajmer, Rajasthan, India – 305001.
Leemark Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.